Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Can-Fite Biopharma Ltd (NY: CANF )

1.855 USD +0.025 (+1.38%)
Streaming Delayed Price Updated: 9:30 AM EST, Dec 4, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,252
Open 1.860
Bid (Size) 1.850 (9)
Ask (Size) 1.870 (8)
Prev. Close 1.830
Today's Range 1.855 - 1.860
52wk Range 1.080 - 4.490
Shares Outstanding 19,981,145
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Can-Fite to Present at Benzinga Global Small Cap Conference on December 8, 2020
Can-Fite to Present at Benzinga Global Small Cap Conference on December 8, 2020 
From Business Wire News Releases
Can-Fite Reports Third Quarter 2020 Financial Results & Provides Clinical Update
Can-Fite Reports Third Quarter 2020 Financial Results & Provides Clinical Update 
From Business Wire News Releases

Performance

YTD
-40.54%
-40.54%
1 Month
+10.43%
+10.43%
3 Month
+2.50%
+2.50%
6 Month
-7.70%
-7.70%
1 Year
-57.83%
-57.83%

More News

Read More
Can-Fite’s Namodenoson Abstract Selected as ‘Best of The Liver Meeting’ in the NASH Category of the American Association of Liver Diseases (AASLD)
From Business Wire News Releases
Can-Fite to Conduct Investor Call to Review Q3 Results and Provide Business Update on Monday, November 30, 2020 at 9:15 a.m. ET
From Business Wire News Releases
Can-Fite Presented NASH Phase II Namodenoson Data at a Late Breaking Session of the American Association for the Study of Liver Diseases (AASLD) Conference
From Business Wire News Releases
Can-Fite to Present its NASH Program in Fireside Chat at the H.C. Wainwright 6th Annual Israel Conference on November 12, 2020
From Business Wire News Releases
4 Penny Stocks On Robinhood To Buy Under $4 Now; Worth The Risk?
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Can-Fite to Host Conference Call to Update Shareholders on Positive Interim Results of its Phase III Psoriasis Study on October 15, 2020
From Business Wire News Releases
Can-Fite Announces Positive Phase III Psoriasis Interim Data Analysis
From Business Wire News Releases
Thinking about buying stock in OraSure Technologies, AMC Entertainment, Can Fite Biopharma, American Airlines, or Canopy Growth Corp?
From PR Newswire
Earnings Scheduled For November 30, 2020
Tags AIH NOAH FRO
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.